149 related articles for article (PubMed ID: 20048211)
41. CD40 ligand-dependent tyrosine nitration of prostacyclin synthase in vivo.
Davis B; Zou MH
Circulation; 2005 Oct; 112(14):2184-92. PubMed ID: 16186418
[TBL] [Abstract][Full Text] [Related]
42. Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries.
Shinohara M; Kawashima S; Yamashita T; Takaya T; Toh R; Ishida T; Ueyama T; Inoue N; Hirata K; Yokoyama M
Cardiovasc Res; 2005 Nov; 68(2):249-58. PubMed ID: 16039635
[TBL] [Abstract][Full Text] [Related]
43. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro.
Sakata Y; Xiang F; Chen Z; Kiriyama Y; Kamei CN; Simon DI; Chin MT
Arterioscler Thromb Vasc Biol; 2004 Nov; 24(11):2069-74. PubMed ID: 15345511
[TBL] [Abstract][Full Text] [Related]
44. Analysis of serum soluble CD40 ligand (sCD40L) in the patients undergoing allogeneic stem cell transplantation: platelet is a major source of serum sCD40L.
Nagasawa M; Zhu Y; Isoda T; Tomizawa D; Itoh S; Kajiwara M; Morio T; Nonoyama S; Shimizu N; Mizutani S
Eur J Haematol; 2005 Jan; 74(1):54-60. PubMed ID: 15613107
[TBL] [Abstract][Full Text] [Related]
45. Therapeutic reendothelialization by induced pluripotent stem cells after vascular injury--brief report.
Yamamoto T; Shibata R; Ishii M; Kanemura N; Kito T; Suzuki H; Miyake H; Maeda K; Tanigawa T; Ouchi N; Murohara T
Arterioscler Thromb Vasc Biol; 2013 Sep; 33(9):2218-21. PubMed ID: 23868941
[TBL] [Abstract][Full Text] [Related]
46. Loss of angiomiR-126 and 130a in angiogenic early outgrowth cells from patients with chronic heart failure: role for impaired in vivo neovascularization and cardiac repair capacity.
Jakob P; Doerries C; Briand S; Mocharla P; Kränkel N; Besler C; Mueller M; Manes C; Templin C; Baltes C; Rudin M; Adams H; Wolfrum M; Noll G; Ruschitzka F; Lüscher TF; Landmesser U
Circulation; 2012 Dec; 126(25):2962-75. PubMed ID: 23136161
[TBL] [Abstract][Full Text] [Related]
47. Activation of transient receptor potential vanilloid 1 accelerates re-endothelialization and inhibits neointimal formation after vascular injury.
Su L; Zhang Y; He K; Wei S; Pei H; Wang Q; Yang D; Yang Y
J Vasc Surg; 2017 Jan; 65(1):197-205.e2. PubMed ID: 26947234
[TBL] [Abstract][Full Text] [Related]
48. Soluble CD40 ligand stimulates CD40-dependent activation of the β2 integrin Mac-1 and protein kinase C zeda (PKCζ) in neutrophils: implications for neutrophil-platelet interactions and neutrophil oxidative burst.
Jin R; Yu S; Song Z; Zhu X; Wang C; Yan J; Wu F; Nanda A; Granger DN; Li G
PLoS One; 2013; 8(6):e64631. PubMed ID: 23785403
[TBL] [Abstract][Full Text] [Related]
49. The therapeutic potential of SA-sCD40L in the orthotopic model of superficial bladder cancer.
Zhang Z; Xu X; Zhang X; Chen X; Chen Q; Dong L; Hu Z; Li J; Gao J
Acta Oncol; 2011 Oct; 50(7):1111-8. PubMed ID: 21247263
[TBL] [Abstract][Full Text] [Related]
50. Transfusion of autologous late-outgrowth endothelial cells reduces arterial neointima formation after injury.
Liu SQ; Li ZL; Cao YX; Li L; Ma X; Zhao XG; Kang AQ; Liu CH; Yuan BX
Cardiovasc Res; 2011 Apr; 90(1):171-81. PubMed ID: 21163831
[TBL] [Abstract][Full Text] [Related]
51. Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.
Cipollone F; Chiarelli F; Davì G; Ferri C; Desideri G; Fazia M; Iezzi A; Santilli F; Pini B; Cuccurullo C; Tumini S; Del Ponte A; Santucci A; Cuccurullo F; Mezzetti A
Diabetologia; 2005 Jun; 48(6):1216-24. PubMed ID: 15868137
[TBL] [Abstract][Full Text] [Related]
52. Cilostazol activates function of bone marrow-derived endothelial progenitor cell for re-endothelialization in a carotid balloon injury model.
Kawabe-Yako R; Ii M; Masuo O; Asahara T; Itakura T
PLoS One; 2011; 6(9):e24646. PubMed ID: 21931795
[TBL] [Abstract][Full Text] [Related]
53. Distinct CD11b+-monocyte subsets accelerate endothelial cell recovery after acute and chronic endothelial cell damage.
Becher UM; Möller L; Tiyerili V; Vasa Nicotera M; Hauptmann F; Zimmermann K; Pfeifer A; Nickenig G; Wassmann S; Werner N
Int J Cardiol; 2014 Apr; 173(1):80-91. PubMed ID: 24602320
[TBL] [Abstract][Full Text] [Related]
54. CD40 ligand promotes Mac-1 expression, leukocyte recruitment, and neointima formation after vascular injury.
Li G; Sanders JM; Bevard MH; Sun Z; Chumley JW; Galkina EV; Ley K; Sarembock IJ
Am J Pathol; 2008 Apr; 172(4):1141-52. PubMed ID: 18349125
[TBL] [Abstract][Full Text] [Related]
55. CD40 ligand binds to alpha5beta1 integrin and triggers cell signaling.
Léveillé C; Bouillon M; Guo W; Bolduc J; Sharif-Askari E; El-Fakhry Y; Reyes-Moreno C; Lapointe R; Merhi Y; Wilkins JA; Mourad W
J Biol Chem; 2007 Feb; 282(8):5143-51. PubMed ID: 17182621
[TBL] [Abstract][Full Text] [Related]
56. The cardiovascular risk factor, soluble CD40 ligand (CD154), but not soluble CD40 is lowered by ultra-endurance exercise in athletes.
Geertsema L; Lucas SJ; Cotter JD; Hock B; McKenzie J; Fernyhough LJ
Br J Sports Med; 2011 Jan; 45(1):42-5. PubMed ID: 18728056
[TBL] [Abstract][Full Text] [Related]
57. Soluble CD40 ligand accumulates in stored blood components, primes neutrophils through CD40, and is a potential cofactor in the development of transfusion-related acute lung injury.
Khan SY; Kelher MR; Heal JM; Blumberg N; Boshkov LK; Phipps R; Gettings KF; McLaughlin NJ; Silliman CC
Blood; 2006 Oct; 108(7):2455-62. PubMed ID: 16772606
[TBL] [Abstract][Full Text] [Related]
58. [Biological effects of soluble CD40 ligand on lung cancer cell line A549 and its mechanism].
Wang TL; Huang JA; Yu GH; Mao YX; Wang GJ; Zhang XG
Ai Zheng; 2004 Nov; 23(11):1278-82. PubMed ID: 15522173
[TBL] [Abstract][Full Text] [Related]
59. Platelet CD40 Mediates Leukocyte Recruitment and Neointima Formation after Arterial Denudation Injury in Atherosclerosis-Prone Mice.
Jin R; Xiao AY; Song Z; Yu S; Li J; Cui MZ; Li G
Am J Pathol; 2018 Jan; 188(1):252-263. PubMed ID: 29037856
[TBL] [Abstract][Full Text] [Related]
60. A critical role for both CD40 and VLA5 in angiotensin II-mediated thrombosis and inflammation.
Senchenkova EY; Russell J; Vital SA; Yildirim A; Orr AW; Granger DN; Gavins FNE
FASEB J; 2018 Jun; 32(6):3448-3456. PubMed ID: 29452567
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
